
Vijaya Diagnostic Centre Ltd. (VIJAY): Vijaya Diagnostic Centre Share Price near 52-week high as stock trades at Rs 1,558.50
Updated: 23 Sept 2026 • 1:51 pm
Posted by:

Vijaya Diagnostic Centre Share Price is trading at Rs 1,558.50, up 2.88% today, and remains close to its 52-week high. The company’s market capitalisation stands at Rs 16,044.98 crore, keeping Vijaya Diagnostic Centre Share Price in focus for stock news, valuation and sector comparison.
Vijaya Diagnostic Centre Share Price is trading at Rs 1,558.50, up Rs 43.60 from the previous close of Rs 1,514.90, and it is positioned close to its 52-week high during today’s market session. The company’s market capitalisation is Rs 16,044.98 crore, placing Vijaya Diagnostic Centre Share Price in the centre of current healthcare stock news. The move is relevant because it confirms a near-yearly high event based on live price data, not on any separate corporate announcement. For readers tracking Vijaya Diagnostic Centre Share Price Today, the market is also pricing the stock against a rich valuation and strong return ratios that stand out inside the healthcare pack. Univest data helps frame the move through price action, fundamentals and sector benchmarks without adding speculation.
Vijaya Diagnostic Centre Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,558.5 |
| Previous Close | Rs 1,514.9 |
| Today's Move | +Rs 43.6 (+2.88%) |
| Open | Rs 1,511.95 |
| High | Rs 1,558.5 |
| Low | Rs 1,510 |
| Turnover | Rs 0.51 crore |
| Market Capitalisation | Rs 16,044.98 crore |
Vijaya Diagnostic Centre Ltd. (VIJAY) traded at Rs 1,558.5 versus the previous close of Rs 1,514.9, a rise of 2.88%. The stock opened at Rs 1,511.95, reached a high of Rs 1,558.5 and touched a low of Rs 1,510.
Vijaya Diagnostic Centre Share Price opened at Rs 1,511.95, moved between Rs 1,510 and Rs 1,558.50, and is last traded at Rs 1,558.50. That places the stock at the top of the day’s range, with a gain of 2.88% versus the previous close. Turnover stands at Rs 0.51 crore, which is a factual traded-value measure for the session. The price action shows that Vijaya Diagnostic Centre Share Price Today is trading close to its 52-week high without implying any fresh event beyond the recorded market level. For investors following Vijaya Diagnostic Centre Share Price Live, the key point is the current price positioning relative to its recent range and yearly high, which keeps Vijaya Diagnostic Centre Stock News on watchlists.
Vijaya Diagnostic Centre Ltd. (VIJAY) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 16,044.98 crore |
| P/E Ratio | 83.22x |
| P/B Ratio | 15.49x |
| ROE | 19.91% |
| ROCE | 30.28% |
| EPS | Rs 18.2 |
| Book Value Per Share | Rs 97.8 |
| Dividend Yield | 0.13% |
Vijaya Diagnostic Centre Ltd. (VIJAY) fundamental metrics show P/E 83.22x, P/B 15.49x, ROE 19.91%, ROCE 30.28%. These figures provide context only and are not a buy or sell signal.
Vijaya Diagnostic Centre Ltd. has a market capitalisation of Rs 16044.98 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 83.22x, P/B at 15.49x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.91% and ROCE of 30.28%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 18.2, book value per share of Rs 97.8, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 45x, median ROE of 13.01%, median ROCE of 15.84%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 83.22x |
| Benchmark Median P/E | 45x |
| Benchmark Average P/E | 90.43x |
| Benchmark P/E Range | 0x to 1,611.72x |
| Company P/B Ratio | 15.49x |
| Benchmark Median P/B | 3.58x |
| Company ROE | 19.91% |
| Benchmark Median ROE | 13.01% |
| Company ROCE | 30.28% |
| Benchmark Median ROCE | 15.84% |
| Company Market Capitalisation | Rs 16,044.98 crore |
| Benchmark Median Market Cap | Rs 513.76 crore |
Vijaya Diagnostic Centre Ltd. (VIJAY) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Vijaya Diagnostic Centre Ltd. (VIJAY) has a P/E ratio of 83.22x, which is above the benchmark median of 45x, a difference of +84.93%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Vijaya Diagnostic Centre Ltd. (VIJAY) has a ROE of 19.91%, which is above the benchmark median of 13.01%, a difference of +53.04%. Vijaya Diagnostic Centre Ltd. (VIJAY) has a ROCE of 30.28%, which is above the benchmark median of 15.84%, a difference of +91.16%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| DR AGARWALS HEALTH CARE L | AGARWALEYE | 15,527.94 | 105.43 | 7.56 | 8.69 | 16.14 |
| Rainbow Children's Medicare Ltd. | RAINBOW | 14,630.17 | 50.81 | 8.5 | 18.1 | 28.25 |
| Metropolis Healthcare Ltd. | METROPOLIS | 12,337.28 | 60.84 | 7.87 | 13.53 | 20.03 |
| PARK MEDI WORLD LIMITED | PARKHOSPS | 12,294.91 | 47.72 | 5.87 | 17.94 | 21.3 |
| Yatharth Hospital & Trauma Care Services Ltd. | YATHARTH | 10,823 | 60.07 | 5.96 | 10.06 | 13.3 |
Vijaya Diagnostic Centre Ltd. (VIJAY) has a P/E ratio of 83.22x compared with the displayed peer median of 60.07x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.91% compares with a peer median of 13.53% across the companies shown in the table. ROCE stood at 30.28% versus the displayed peer median of 20.03%, providing a capital-efficiency comparison. Vijaya Diagnostic Centre Ltd. (VIJAY) has a market capitalisation of Rs 16,044.98 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Vijaya Diagnostic Centre
- Vijaya Diagnostic Centre Share Price is trading at Rs 1,558.50, up 2.88% from the previous close of Rs 1,514.90.
- The stock is close to its 52-week high, which keeps Vijaya Diagnostic Centre Share Price in the 52 Week High Stocks category.
- Market capitalisation is Rs 16,044.98 crore, which places the company above the industry median market cap.
- PE is 83.22 and PB is 15.49, both of which are high versus the same-industry median values.
- ROE of 19.91% and ROCE of 30.28% provide direct fundamental context for Vijaya Diagnostic Centre Share Price.
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. In Univest stock coverage, Vijaya Diagnostic Centre Share Price is tracked as part of the listed healthcare universe, where company-level financial ratios and sector benchmarks are compared with peer companies. The latest Univest figures show revenue and profit progression across recent quarters, while the company’s market cap, EPS, book value and dividend yield provide additional context for stock market readers following Vijaya Diagnostic Centre Stock News and Vijaya Diagnostic Centre Company News.
Frequently Asked Questions
Why is Vijaya Diagnostic Centre Share Price near its 52-week high?
Ans. Vijaya Diagnostic Centre Share Price is trading at Rs 1,558.50, only a short distance from its yearly peak. The move is confirmed by live price data and not by any stated corporate catalyst.
What is Vijaya Diagnostic Centre Share Price today?
Ans. Vijaya Diagnostic Centre Share Price is Rs 1,558.50, up 2.88% from the previous close of Rs 1,514.90. The stock is trading at the top of its day’s range at the time of reporting.
What is the market capitalisation of Vijaya Diagnostic Centre?
Ans. Vijaya Diagnostic Centre has a market capitalisation of Rs 16,044.98 crore. That size is well above the same-industry median in the healthcare benchmark and is useful for comparison with listed peers.
How does Vijaya Diagnostic Centre compare on valuation?
Ans. Vijaya Diagnostic Centre Share Price is supported by a PE ratio of 83.22 and a PB ratio of 15.49. Both are materially above the same-industry median, which frames the current valuation discussion.
What do Vijaya Diagnostic Centre earnings metrics show?
Ans. EPS is Rs 18.2, book value is Rs 97.8 and dividend yield is 0.13%. These figures give a direct snapshot of earnings, accounting net worth and historical payout relative to Vijaya Diagnostic Centre Share Price.
How does Vijaya Diagnostic Centre perform on return ratios?
Ans. ROE is 19.91% and ROCE is 30.28%. Both exceed the same-industry medians, which provides context for Vijaya Diagnostic Centre Share Price when compared with the healthcare peer group.
Which sector and industry does Vijaya Diagnostic Centre belong to?
Ans. Vijaya Diagnostic Centre operates in the Healthcare sector and the Hospital & Healthcare Services industry. That classification is central to how Vijaya Diagnostic Centre Share Price is compared against sector benchmarks and peers.
What should investors monitor next in Vijaya Diagnostic Centre Share Price?
Track Vijaya Diagnostic Centre Share Price on Univest
Use Vijaya Diagnostic Centre Ltd. (VIJAY) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Vijaya Diagnostic Centre Share Price on Univest for live share price updates, company financial ratios, market cap, sector comparison, 52-week levels and stock insights. Univest also helps users follow Vijaya Diagnostic Centre Share Price Today, Vijaya Diagnostic Centre Latest News and the broader healthcare market update in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Recent Articles

Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026

Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026

Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026

Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





